Inventor
CONGXIN LIANG
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
C07BGeneral methods of organic chemistry15%
C07CAcyclic or carbocyclic compounds5%
Y02PClimate change mitigation technologies in the production or processing of goods5%
PatentTitleYear
RE050799JAK1 selective inhibitors and uses thereof202612,297,206Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic substance of salt202512,209,080Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereof202512,195,476Synthesis method of furoimidazopyridine compound, crystal form of furoimidazopyridine compound, and crystal form of salt thereof2025RE049834Jak1 selective inhibitors and uses thereof2024Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2024–2026Patents assigned to HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD (4)· patent assignee history
2024–2026Based in US· patent location history
2025Patents assigned to BIOHAVEN THERAPEUTICS LTD (1)· patent assignee history
2025Patents assigned to EQUINOX SCIENCES LLC (1)· patent assignee history
2026Patents assigned to HANGZHOU HIGHLIGHTII PHARMACEUTICAL CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD | 4 | 2024–2026 |
| BIOHAVEN THERAPEUTICS LTD | 1 | 2025 |
| EQUINOX SCIENCES LLC | 1 | 2025 |
| HANGZHOU HIGHLIGHTII PHARMACEUTICAL CO LTD | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2024–2026 |